Emergency Arbitration Procedures under the Rules of the Singapore International Arbitration Centre (SIAC)
BCDR International Arbitration Review · 01.12.2023 · 10 (Issue 2) · 269-296
DOI: 10.54648/bcdr2023016 ↗Kurz gefasst
Fachartikel in der Zeitschrift BCDR International Arbitration Review, erschienen am 01.12.2023. Verfasst von Vivekananda Neelakantan und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Interim measures play an essential role in the resolution of cross-border disputes, particularly when there is a pressing need for some form of protection pending the consideration of the main dispute and the issue of a final award. Historically, a party wishing to obtain interim relief in arbitration had either to apply to the arbitral tribunal or to a national court, but if the arbitral tribunal had not yet been constituted, a national court was the only available forum. The position has changed since the introduction by a number of international arbitration institutions of emergency arbitration procedures. This article reviews the emergency arbitration practice and procedure under the Arbitration Rules of the Singapore International Arbitration Centre (SIAC) (7th Edition, 1 January 2025).
Zitieren
APA
Neelakantan, V., & Giorgadze, V. (2023). Emergency Arbitration Procedures under the Rules of the Singapore International Arbitration Centre (SIAC). BCDR International Arbitration Review, 10(Issue 2), 269-296. https://doi.org/10.54648/bcdr2023016
Vancouver
Neelakantan V, Giorgadze V. Emergency Arbitration Procedures under the Rules of the Singapore International Arbitration Centre (SIAC). BCDR International Arbitration Review. 2023;10(Issue 2):269-296. doi:10.54648/bcdr2023016
BibTeX
@article{Neelakantan2023,
author = {Neelakantan, Vivekananda and Giorgadze, Vakhtangi},
title = {Emergency Arbitration Procedures under the Rules of the Singapore International Arbitration Centre (SIAC)},
journal = {BCDR International Arbitration Review},
year = {2023},
volume = {10},
number = {Issue 2},
pages = {269--296},
doi = {10.54648/bcdr2023016}
}
EUVIMED